It included the tumor necrosis factor receptor TNFRSF1A, which contributes to AD pathogenesis by mediating neuronal cell death (33), as the most significantly increased CREB3L2-ATF4 target gene (P = 1.26 × 10−35). The gene discussed is TNFRSF1A; the disease is Alzheimer disease.